Literature DB >> 11819298

Molecular biology of Barrett's esophagus and esophageal cancer:role of p53.

Alan G Casson.   

Abstract

Entities:  

Year:  1998        PMID： 11819298      PMCID： PMC4761539          DOI： 10.3748/wjg.v4.i4.277

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  10 in total

1.  Frequent mutation of the p53 gene in human esophageal cancer.

Authors:  M C Hollstein; R A Metcalf; J A Welsh; R Montesano; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

Review 2.  Barrett's oesophagus.

Authors:  J Dent; C G Bremner; M J Collen; R C Haggitt; S J Spechler
Journal:  J Gastroenterol Hepatol       Date:  1991 Jan-Feb       Impact factor: 4.029

Review 3.  Clinical implications of the p53 tumor-suppressor gene.

Authors:  C C Harris; M Hollstein
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  p53 alterations in oesophageal cancer: association with clinicopathological features, risk factors, and survival.

Authors:  A G Casson; M Tammemagi; S Eskandarian; M Redston; J McLaughlin; H Ozcelik
Journal:  Mol Pathol       Date:  1998-04

Review 6.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

7.  p53 gene mutations in Barrett's epithelium and esophageal cancer.

Authors:  A G Casson; T Mukhopadhyay; K R Cleary; J Y Ro; B Levin; J A Roth
Journal:  Cancer Res       Date:  1991-08-15       Impact factor: 12.701

Review 8.  Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review.

Authors:  R Montesano; M Hollstein; P Hainaut
Journal:  Int J Cancer       Date:  1996-06-21       Impact factor: 7.396

9.  Endoscopic surveillance of Barrett's esophagus. Does it help?

Authors:  J M Streitz; C W Andrews; F H Ellis
Journal:  J Thorac Cardiovasc Surg       Date:  1993-03       Impact factor: 5.209

10.  The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents.

Authors:  Y Nabeya; F Loganzo; P Maslak; L Lai; A R de Oliveira; G K Schwartz; M L Blundell; N K Altorki; D P Kelsen; A P Albino
Journal:  Int J Cancer       Date:  1995-02-20       Impact factor: 7.396
  10 in total
  4 in total

1.  Infrequent p53 gene mutation and expression of the cardia adenocarcinomas from a high-incidence area of Southwest China.

Authors:  Xiu-Jie Wang; Shu-Lan Yuan; Chang-Ping Li; Naoko Iida; Hideaki Oda; Shigetoshi Aiso; Takatoshi Ishikawa
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

2.  Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions.

Authors:  Ming-Yao Wu; Ying-Rui Liang; Xian-Ying Wu; Chu-Xiang Zhuang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Experimental and clinicopathologic study on the relationship between transcription factor Egr-1 and esophageal carcinoma.

Authors:  M Y Wu; M H Chen; Y R Liang; G Z Meng; H X Yang; C X Zhuang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

4.  Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines.

Authors:  Miao-Wang Hao; Ying-Rui Liang; Yan-Fang Liu; Li Liu; Ming-Yao Wu; Huan-Xing Yang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.